1. Evolving strategies to overcome barriers in CAR-T cell therapy for acute myeloid leukemia
   Chanukya K. Colonne et al, 2024, Expert Review of Hematology CrossRef
2. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy
   Kosuke Murakami et al, 2024, Frontiers in Immunology CrossRef
3. Role of Biomarkers in FLT3 AML
   null Nitika et al, 2022, Cancers CrossRef
4. Overcoming tumor resistance mechanisms in CAR-NK cell therapy
   Antonio Valeri et al, 2022, Frontiers in Immunology CrossRef
5. CD155 as an emerging target in tumor immunotherapy
   Jiang-Wan Wu et al, 2024, International Immunopharmacology CrossRef
6. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
   Zhenlong Li et al, 2024, Cell CrossRef
7. Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
   Xinyu Guo et al, 2023, Heliyon CrossRef
8. The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia
   Asal Barshidi et al, 2024, Cell Communication and Signaling CrossRef
9. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
   Tatjana Sauerer et al, 2023, Molecular Cancer CrossRef
10. Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia
    Katharina Seel et al, 2024, Cancer Immunology, Immunotherapy CrossRef
11. Bispecific anti-CD3×anti-CD155 antibody mediates T-cell immunotherapy in human haematologic malignancies
    Li Ma et al, 2023, Investigational New Drugs CrossRef
12. Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
    Chenyu Zha et al, 2024, Annals of Hematology CrossRef
13. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?
    Yang Liu et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
14. Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
    Yanyu Wang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef